These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


438 related items for PubMed ID: 6334697

  • 1. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.
    Wewers MD, Rennard SI, Hance AJ, Bitterman PB, Crystal RG.
    J Clin Invest; 1984 Dec; 74(6):2208-18. PubMed ID: 6334697
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Demonstration by in situ hybridization of dissimilar IL-1 beta gene expression in human alveolar macrophages and blood monocytes in response to lipopolysaccharide.
    Bernaudin JF, Yamauchi K, Wewers MD, Tocci MJ, Ferrans VJ, Crystal RG.
    J Immunol; 1988 Jun 01; 140(11):3822-9. PubMed ID: 3259599
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. IL-1 beta-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1 beta release limitation is ICE independent.
    Wewers MD, Dare HA, Winnard AV, Parker JM, Miller DK.
    J Immunol; 1997 Dec 15; 159(12):5964-72. PubMed ID: 9550394
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Disparate cytochemical characteristics and production of cytokines and prostaglandin E2 by human mononuclear phagocytes from the blood, lung, and peritoneal cavity.
    Friedlander MA, Hilbert CM, Wu YC, Finegan CK, Rich EA.
    J Lab Clin Med; 1994 Apr 15; 123(4):574-84. PubMed ID: 8145006
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
    Hunninghake GW.
    Am Rev Respir Dis; 1984 Apr 15; 129(4):569-72. PubMed ID: 6608889
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing.
    Herzyk DJ, Allen JN, Marsh CB, Wewers MD.
    J Immunol; 1992 Nov 01; 149(9):3052-8. PubMed ID: 1401931
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human lung macrophages enhance and inhibit lymphocyte proliferation.
    Liu MC, Proud D, Schleimer RP, Plaut M.
    J Immunol; 1984 Jun 01; 132(6):2895-903. PubMed ID: 6609963
    [Abstract] [Full Text] [Related]

  • 18. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
    Venet A, Hance AJ, Saltini C, Robinson BW, Crystal RG.
    J Clin Invest; 1985 Jan 01; 75(1):293-301. PubMed ID: 3871200
    [Abstract] [Full Text] [Related]

  • 19. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).
    Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ.
    J Immunol; 1987 Aug 01; 139(3):788-93. PubMed ID: 3298433
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
    Thomassen MJ, Yi T, Raychaudhuri B, Malur A, Kavuru MS.
    Clin Immunol; 2000 May 01; 95(2):85-92. PubMed ID: 10779401
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.